Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 14:28:06 10/09/2026 +04			5-day change	1st Jan Change
2,840.80 ^INR	-1.57%		-3.59%	+14.97%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	481,249	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	24.41%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	481,249	481,249
Change	-	-18.99%	58.51%	48.08%	-20.64%	24.41%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	41.3x	35.9x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.2x	15.3x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.3x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.3x	10.2x
EV / Revenue	0x	0x	0x	0x	0x	11.3x	10.2x
EV / EBITDA	0x	0x	0x	0x	0x	32.4x	28.2x
EV / EBIT	0x	0x	0x	0x	0x	32.7x	28.1x
EV / FCF	0x	0x	0x	0x	0x	40.1x	36.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.49%	2.74%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.04%	1.04%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,840.80	2,840.80
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	41.97x	-	-	1.02%	5.14B
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	18.62x	6.35x	15.50x	2.33%	353.48B
Weighted average by Cap.	22.94x	7.53x	17.31x	2.04%